Related Experiment Video
Updated: May 5, 2026
06:02
Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
7.0K
Taxanes: their impact on gynecologic malignancy
Carlton L Schwab1, Diana P English, Dana M Roque
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, USA.
Anti-Cancer Drugs
|December 5, 2013
Summary
Taxanes, including paclitaxel and docetaxel, are highly effective chemotherapeutic agents for gynecologic cancers. Ongoing research explores new formulations and combinations, solidifying their role in ovarian, uterine, and cervical cancer treatment.
Area of Science:
- Oncology
- Pharmacology
Background:
- Taxanes (paclitaxel, docetaxel) have been pivotal in gynecologic cancer treatment for 30 years.
- Their unique properties include microtubule stabilization, antiangiogenesis, and radiosensitization.
Purpose of the Study:
- To review the development and efficacy of taxanes in gynecologic malignancies.
- To discuss current research, alternative formulations, and combination therapies.
- To address future directions for taxane-based chemotherapy in ovarian, uterine, and cervical cancers.
Main Methods:
- Literature review of taxane efficacy in gynecologic cancers.
- Analysis of data on dose, timing, intervals, and response rates.
- Exploration of novel treatment strategies and formulations.
Main Results:
- Taxanes are among the most active agents for gynecologic cancers.
- Research continues to expand, focusing on new applications and combinations.
- Established efficacy supports their continued use.
Conclusions:
- Taxane-based chemotherapy is an integral and enduring treatment for gynecologic cancers.
- Future research will likely enhance their role through innovative approaches.
- These agents demonstrate remarkable activity and broad applicability.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
01:10Drugs that Destabilize Microtubules
3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:57Targeted Cancer Therapies
1.4K
1.4K
02:49Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81